<DOC>
	<DOCNO>NCT02677844</DOCNO>
	<brief_summary>The purpose study determine : - The effect single increase dos study drug , abemaciclib , healthy participant . - The relationship amount abemaciclib electrical trace heart rhythm abemaciclib give . - How much abemaciclib find bloodstream long body take get rid . Information side effect occur collect . The study enroll two group ( cohort ) participant . Each group complete 4 study period . This study expect last 3 month . Screening may occur 28 day prior enrollment . All participant undergo follow-up assessment approximately 21 day administration final dose study drug .</brief_summary>
	<brief_title>A Study Abemaciclib Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>Overtly healthy male female , determine medical history physical examination Male participant sterile Female participant must childbearing potential Have know allergy abemaciclib , related compound , component formulation Have abnormality 12lead electrocardiogram ( ECG ) include Fridericia 's correct QT interval ( QTcF ) great 450 millisecond ( m ) ( male ) great 470 m ( female ) Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug Have gastrointestinal disorder cause clinically significant symptom nausea , vomit , diarrhea , malabsorption syndrome , constipation Additional Exclusion Criterion Participants Enrolled Cohort 2 : Have know hypersensitivity loperamide hydrochloride excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>